High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

A. N. Bonde; T. Martinussen; C. Y. Lee; J. Bhattacharya; G. Y. H. Lip; L. Staerk; G. Gislason; C. Torp-Pedersen; J. B. Olesen; M. Hlatky

doi:10.1093/eurheartj/ehz745.1155

High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

A. N. Bonde, T. Martinussen, C. Y. Lee, J. Bhattacharya, G. Y. H. Lip, L. Staerk, G. Gislason, C. Torp-Pedersen, J. B. Olesen, M. Hlatky

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	P4779
Tidsskrift	European Heart Journal
Vol/bind	40
Udgave nummer	Supplement 1
Sider (fra-til)	2983
Antal sider	1
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehz745.1155
Status	Udgivet - 2019

Adgang til dokumentet

10.1093/eurheartj/ehz745.1155

Citationsformater

Bonde, A. N., Martinussen, T., Lee, C. Y., Bhattacharya, J., Lip, G. Y. H., Staerk, L., Gislason, G., Torp-Pedersen, C., Olesen, J. B., & Hlatky, M. (2019). High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. European Heart Journal, 40(Supplement 1), 2983. [P4779]. https://doi.org/10.1093/eurheartj/ehz745.1155

High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. / Bonde, A. N.; Martinussen, T.; Lee, C. Y.; Bhattacharya, J.; Lip, G. Y. H.; Staerk, L.; Gislason, G.; Torp-Pedersen, C.; Olesen, J. B.; Hlatky, M.

I: European Heart Journal, Bind 40, Nr. Supplement 1, P4779, 2019, s. 2983.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Bonde, AN, Martinussen, T, Lee, CY, Bhattacharya, J, Lip, GYH, Staerk, L, Gislason, G, Torp-Pedersen, C, Olesen, JB & Hlatky, M 2019, 'High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban', European Heart Journal, bind 40, nr. Supplement 1, P4779, s. 2983. https://doi.org/10.1093/eurheartj/ehz745.1155

Bonde, A. N. ; Martinussen, T. ; Lee, C. Y. ; Bhattacharya, J. ; Lip, G. Y. H. ; Staerk, L. ; Gislason, G. ; Torp-Pedersen, C. ; Olesen, J. B. ; Hlatky, M. / High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. I: European Heart Journal. 2019 ; Bind 40, Nr. Supplement 1. s. 2983.

@article{43c55d6313d6480f8573fbe6d711a614,

title = "High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban",

author = "Bonde, {A. N.} and T. Martinussen and Lee, {C. Y.} and J. Bhattacharya and Lip, {G. Y. H.} and L. Staerk and G. Gislason and C. Torp-Pedersen and Olesen, {J. B.} and M. Hlatky",

year = "2019",

doi = "10.1093/eurheartj/ehz745.1155",

language = "English",

volume = "40",

pages = "2983",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Supplement 1",

}

TY - ABST

T1 - High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban

AU - Bonde, A. N.

AU - Martinussen, T.

AU - Lee, C. Y.

AU - Bhattacharya, J.

AU - Lip, G. Y. H.

AU - Staerk, L.

AU - Gislason, G.

AU - Torp-Pedersen, C.

AU - Olesen, J. B.

AU - Hlatky, M.

PY - 2019

Y1 - 2019

U2 - 10.1093/eurheartj/ehz745.1155

DO - 10.1093/eurheartj/ehz745.1155

M3 - Conference abstract in journal

VL - 40

SP - 2983

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - Supplement 1

M1 - P4779

ER -